Tatva Chintan Pharma Chem has reported results for second quarter ended September 30, 2021.
The company has reported over 10-fold jump in its net profit at Rs 30.72 crore for the quarter under review as compared to Rs 2.92 crore for the same quarter in the previous year. Total income of the company increased by 98.17% at Rs 119.28 crore for Q2FY22 as compared Rs 60.19 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 9-fold jump in its net profit attributed to the owners at Rs 32.41 crore for the quarter under review as compared to Rs 3.56 crore for the same quarter in the previous year. Total income of the company increased by 2-fold at Rs 126.42 crore for Q2FY22 as compared Rs 61.99 crore for the corresponding quarter previous year.
